Australian Pharmacist

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

New research has explored the benefits of pharmacists joining allied health teams in Australian residential care facilities, with promising results. Australian Pharmacist spoke with Nicole...

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Pharmacists play a vital role supporting patients with chronic pain. Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...

Compounding environments must be designed to minimise contamination risk —  including keeping meal breaks well away from the bench.

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...